CHC Healthcare Group (TPE:4164)
Taiwan · Delayed Price · Currency is TWD 30.50
-0.20 (-0.65%)
Apr 24, 2026, 1:30 PM CST
CHC Healthcare Group Revenue
In the year 2025, CHC Healthcare Group had annual revenue of 4.40B TWD with 22.15% growth. CHC Healthcare Group had revenue of 1.21B in the quarter ending December 31, 2025, with 18.40% growth.
Revenue
4.40B
Revenue Growth
+22.15%
P/S Ratio
1.35
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.40B | 797.71M | 22.15% |
| Dec 31, 2024 | 3.60B | -276.56M | -7.13% |
| Dec 31, 2023 | 3.88B | 902.79M | 30.35% |
| Dec 31, 2022 | 2.97B | 534.79M | 21.92% |
| Dec 31, 2021 | 2.44B | -115.35M | -4.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 20.51B |
| PharmaEssentia | 15.63B |
| Formosa Laboratories | 4.85B |
| Hi-Clearance | 4.28B |
| Formosa Optical Technology | 4.13B |
| Sinphar Pharmaceutical | 3.37B |
| Savior Lifetec | 1.20B |
| Mycenax Biotech | 740.24M |